Correlation of Sodium Thiopentone Dosage with Seizure Duration in Patients Undergoing Electroconvulsive Therapy: An Observational Prospective Study
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.286 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Chaudhari Tejalben A und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background and Aim: There are very few studies evaluating the correlation between sodium thiopentone dosage and seizure duration in patients undergoing electroconvulsive therapy (ECT). We aimed to investigate this correlation and assess whether a history of previous ECT sessions influences the dosage requirement of thiopentone.
Methods
A total of 189 patients aged 18–60 years, of either sex, belonging to ASA physical status I–III and scheduled for ECT, were included in this study after obtaining approval from the Institutional Ethics Committee. The number of previous ECT sessions was recorded. Baseline heart rate, ECG, mean arterial pressure, and SpO₂ were monitored. General anesthesia was induced with 2.5% sodium thiopentone administered until loss of the eyelid reflex, and the dose required was recorded. Succinylcholine (0.5 mg/kg) was then administered. Seizure duration and recovery time were recorded. Descriptive statistical analysis was performed using SPSS version 28.
Results
Among the 189 patients, 84% were male and 16% were female. The mean age and body weight were 33.16 ± 11.60 years and 60.95 ± 11.71 kg, respectively. The mean thiopentone dose administered was 2.73 ± 0.56 mg/kg, while the mean seizure duration was 28.87 ± 10.07 seconds. The mean recovery time was 5.54 ± 1.33 minutes. The thiopentone dosage required during repeated ECT sessions remained similar. Heart rate showed a slight increase for up to 2 minutes after induction. Patients receiving ≤4 mg/kg of thiopentone demonstrated an average seizure duration of ≥28 seconds.
Conclusion
We conclude that sodium thiopentone, when administered in optimal doses, does not adversely affect the therapeutic seizure duration during ECT and provides timely recovery. Furthermore, a history of repeated ECT sessions does not significantly influence the thiopentone dosage requirement.
Zitieren
APA
A, C. T., R, S. S., & Krupali, P. (2026). Correlation of Sodium Thiopentone Dosage with Seizure Duration in Patients Undergoing Electroconvulsive Therapy: An Observational Prospective Study. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.286
Vancouver
A CT, R SS, Krupali P. Correlation of Sodium Thiopentone Dosage with Seizure Duration in Patients Undergoing Electroconvulsive Therapy: An Observational Prospective Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.286
BibTeX
@article{A2026,
author = {A, Chaudhari Tejalben and R, Soni Sweta and Krupali, Patel},
title = {Correlation of Sodium Thiopentone Dosage with Seizure Duration in Patients Undergoing Electroconvulsive Therapy: An Observational Prospective Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.286}
}
EUVIMED